Stocks To Buy Now Blog

All posts by Christopher

Pure Extracts Technologies Corp.’s (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Subsidiary Pure Mushrooms Corp. Submits Application to Health Canada for a Dealer’s License

  • Pure Extracts Technologies Corp.’s subsidiary Pure Mushrooms Corp. has submitted an application to Health Canada for a Dealer’s License
  • Award of a Dealer’s License will enable company to procure controlled substances, conduct research, carry out business-to-business sales
  • Pure Extracts has recently commenced a study into psilocybin-based active treatments, with research set to be carried out under auspices of Toronto Institute of Pharmaceutical Technology
  • Functional mushroom, psychedelic drug market is forecast to grow to value of $6.85 billion by 2027
Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, announced that its wholly owned subsidiary, Pure Mushrooms Corp., had submitted an application to Health Canada for a Dealer’s License under the Controlled Drugs and Substances Act (“CDSA”) (https://ibn.fm/W0X2t). Under the CDSA’s regulations, companies are required to obtain a license issued by Health Canada to carry out a variety of regulated activities with controlled substances. Among other items, the award of a license would effectively enable Pure Mushrooms Corp. to:
  • Procure controlled substances, including by import, synthesis, propagation, cultivation and harvesting of psychedelic mushrooms for psilocybin extraction
  • Research and manufacture of controlled substances such as psilocybin and psilocin
  • Business-to-business sale of controlled substances, including by export
  • Sell controlled substances via pharmacies
Prior to Pure Mushrooms Corp.’s license application, Pure Extracts had revealed that it had already commenced a study into the formulation and manufacturing of psilocybin-based active treatments, with oral tablets, capsules and nasal gels set to be used as investigational products. The study, which was set to focus on the formulation, manufacturing and clinical bioavailability testing of rapid onset psilocybin forms, was being carried out ahead of the company’s Dealer’s License application and, as such, was to be carried out at the Toronto Institute of Pharmaceutical Technology (“TIPT”) under the auspices of Dr Alexander MacGregor, a key scientific advisor to the company (https://ibn.fm/X7n3K). Pure Extracts has actively sought to diversify its existing toll processing and extraction businesses through a new business vertical into the functional mushrooms sector. To that end, the company recently announced that it had begun work on a fourth unit within its 10,000 square foot, British-Columbia based, purpose-built facility, destined towards facilitating its research and development into psilocybin and functional mushrooms as a whole (https://ibn.fm/JcsJV). Gaining a Dealer’s License from Health Canada would allow Pure Mushrooms Corp., the ability to carry out extraction research and development into psychedelic compounds such as psilocybin and psilocin. This in turn would prepare the company to work with partners such as medical doctors, pharmaceutical companies and pharmacies in an eventual future in which clinical trials could lead to the advancement of micro-dosing and the legalization of psychedelics. Pure Extracts CEO Ben Nikolaevsky stated in reference to the company’s Dealer’s License application, “We are grateful to have the support of one of Canada’s premiere consulting companies with subject matter proficiency in cannabis and other regulated consumer product industries in assisting that we submitted a fully compliant Dealer’s Licence application to Health Canada. As a plant-based extractor bringing functional mushroom products to market in Q2, we are very excited to be laying the groundwork for our move into the controlled substances world of psychedelic extracts.” For more information, visit the company’s website at www.PureExtractsCorp.com. NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

United Medical Equipment Business Solutions Network Positioned to Assist as Widespread Rapid Testing Gains Momentum

  • New York City ramps up rapid testing efforts, opens 11 rapid-testing sites; others to follow
  • Mayor notes that low-cost, rapid-testing made available to public is key to accelerating economy’s re-opening
  • UME offers rapid -testing kits, provides products and services essential for curbing pandemic and jumpstarting economic recovery

United Medical Equipment Business Solutions Network (“UME”), a trusted supplier of COVID-19 antigen and antibody testing kits, is offering a key product that could impede the spread of the virus and speed up economic recovery. A top U.S. testing official announced a scale-up in the country’s diagnostic efforts, touting both health and economic benefits of rapid testing outside the lab. New York City is wasting no time to leverage the power of this low-cost, high-impact option as the city has announced the launch of its Forward Rapid-Test Program (https://ibn.fm/RmtcD).

The program will make low-cost rapid testing available to the broader public to support economic recovery by enabling businesses to more safely re-open. The city has initially announced that 11 sites will open with the capacity to conduct more than 5,000 tests every day. Additional locations are planned across the city and other parts of the state in the coming weeks.

State officials have noted that testing will be a key part of New York’s post-pandemic recovery because it will help the state accelerate the re-opening of its economy. Testing sites have been situated throughout the city to encourage and support economic activity while minimizing risks to people’s health.

The widespread rapid testing is being rolled out in other countries too. The UK government is also looking at introducing rapid lateral-flow testing to open the parts of the economy that could not open last year, including night clubs and theaters. “That [rapid testing], in combination with vaccination, will probably be the route forward,” said UK Prime Minister Boris Johnson (https://ibn.fm/r5rYk).

As a company committed to providing essential products and services during the pandemic, UME is a trusted supplier of FDA-approved COVID-19 rapid test kits (https://ibn.fm/48e2i). The rapid test is designed to detect coronavirus antibodies in the bloodstream of infected individuals within 10 minutes, which helps position the company at the core of the strategy to bring both economy and society back to normal. The test can also help identify whether a person has protection against the coronavirus.

Finally, UME also offers a unique mobile solution that involves on-call onsite COVID-19 Rapid Testing Mobile units. These units involve mobile testing specialists and experienced medical staff members who provide onsite COVID-19 rapid testing. Capable of nationwide deployment for extended periods, they are especially beneficial for securing employee safety. With an offering deemed essential during the pandemic, UME is well-positioned as an all-around provider of highly-sought-after products and services that may prove crucial for getting the society and economy back to normal.

For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

Asia Broadband Inc. (AABB) Inches Closer to Fulfilling its Strategic Vision and Goal

  • Asia Broadband Inc. recently signed a letter of intent (“LOI”) to acquire a 200-hectare property housing two gold mining sites, a processing facility and existing infrastructure
  • The property, estimated to be worth about $30 million, is part of the bigger picture as the company is expected to launch a 100% gold-backed token soon to diversify its revenue generation streams
  • The company outlined its AABB Gold Token’s characteristics in a recent news release
Asia Broadband (OTC: AABB), a resource company focused on the production, supply, and sale of precious and base metals, primarily to Asian markets, has made strides on several fronts since its February 2021 development update on the soon-to-be-launched AABB Wallet and AABB Gold token. According to recent news releases, AABB signed a letter of intent (“LOI”) to purchase an historic production gold mine property and on-site processing facilities in the prolific mining region of Mascota in Jalisco, Mexico, and also clarified the exact characteristics of the AABB Gold token (“AABBG”). The signed LOI sets the wheels in motion for the eventual acquisition of the 200-hectare property, located about 3 kilometers from Barra de Navidad – a small town on the western coastline of Mexico’s Jalisco state – subject to further due diligence and negotiations. The property houses two mine sites, a processing facility capable of processing 50 tons of gold per day and other existing infrastructure (https://ibn.fm/p1vuz). In total, Asia Broadband is expected to pay about $30 million for the property, an investment that will bring the company closer to fulfilling its strategic vision and goal. Fundamentally, AABB aims to differentiate itself from its competitors as well as increase shareholder value by launching a gold-backed digital currency, wallet and exchange. It will back its gold token with physical gold acquired from future mining production, such as mining sites at the 200-hectare property, and gold purchased from cash reserves or credit. So, the purchase is part of a bigger picture. Per its February development update, AABB’s wallet and token developer Core Holdings Corp (“CSHC”) was at an advanced stage of testing the wallet applications on both iOS and Android, in addition to continuing the enhancement of AABB’s gold token website. The developer had also begun the creation of AABB’s cryptocurrency exchange (https://ibn.fm/JEAzu). With the information on the progress of the development of AABB’s wallet and exchange already in the public domain, Asia Broadband sought to provide a similar level of clarity regarding its gold token. In the March 9 news release (https://ibn.fm/xAeza), AABB pointed out that its cryptocurrency token will have the following characteristics:
  • AABBG will be backed 100% by physical gold held by AABB
  • At present, AABB holds $30 million in physical gold
  • AABB will release approximately 5.5 million tokens in the initial token release
  • The price of each token will be equivalent to the current price of one-tenth (0.1) gram of gold plus a 2% transaction fee
  • The price of each token will be tied to and supported by AABB at the market price of gold at a minimum
  • The minimum supported price of AABBG will increase or decrease according to the fluctuation in the price of gold
  • The price of AABBG will also be driven by market demand
  • Purchase of AABBG will be through AABB Wallet
  • Buyers will need to hold existing cryptocurrencies to purchase AABBG
  • Purchase of AABBG will be finalized upon depositing existing cryptocurrencies from third-party wallets into AABB wallet in exchange for AABBG
  • AABB Wallet will allow the intra-wallet transfer of AABBG between purchasers and people with AABB Wallet
  • AABBG tokens will not be exchangeable within the AABB Wallet for other cryptocurrencies
Being a source of shareholder value, the AABB Gold token is a strategic offering aimed at diversifying the company’s revenue. AABB will rely on two revenue-generating streams: transaction fees and the token’s market-demand-driven price appreciation. The company anticipates that an increase in the token circulation will boost the revenue earned from transaction fees, its primary stream. At the same time, AABB is banking on the limited release of the tokens as well as the expanded use and velocity of token exchanges as the main drivers of growth for its secondary stream. Notably, gold-backed tokens are attractive investment options because they offer more stability than other digital currencies (https://ibn.fm/vLrqP), suggesting that Ethereum-based AABBG is bound to appeal to cryptocurrency enthusiast upon launch. Asia Broadband’s objective is for AABBG to become a worldwide standard of exchange that is secured and trusted with gold backing. With the recent announcement regarding the LOI, AABB’s strategic approach and AABBG’s attractiveness as a gold-backed token due to its inherent stability, the conditions seem favorable for the company to actualize this goal. For more information, visit the company’s website at www.AsiaBroadbandInc.com. NOTE TO INVESTORS: The latest news and updates relating to AABB are available in the company’s newsroom at https://ibn.fm/AABB

Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Working on Gen 3 Fluid-to-Drain Liquid Waste Management System for Hospitals

  • Fluid management systems, accessories market forecast at 13.6% CAGR to $16.1 billion by 2025
  • Skyline Medical’s STREAMWAY(R) System disrupts today’s standard of manually moving waste fluid for disposal
  • STREAMWAY Systems eliminates waste transport, disposal costs, equipment relocation and risk of exposure to potentially contaminated fluids.

For every healthcare facility, particularly hospitals and surgical centers, disposal of waste fluids presents a unique set of challenges related not only to regulations but also staff safety. Improper disposal can result in hefty fines and possibly risk exposure to infectious fluids. For the most part, the legacy technology of draining fluid into a canister is the hospital standard, making the industry ripe for innovation. After a year of the coronavirus pandemic leading to postponements of countless elective surgeries, Skyline Medical, a division of Predictive Oncology (NASDAQ: POAI), looks to have well-timed renewing development of its new Generation 3 STREAMWAY(R) System for direct-to-drain fluid waste management.

According to analysts at MarketsandMarkets, the fluid management systems and accessories market is projected to reach $16.1 billion in 2025 from $8.5 billion in 2020, expanding at a 13.6% compound annual growth rate (https://ibn.fm/Vo563). The firm cites several growth drivers, including an increasing number of minimally invasive surgeries, more government funds and grants for endosurgical procedures and a rising number of ESRD (end stage renal disease) patients. They also point to technological advancements in fluid management systems, which falls right into Skyline Medical’s wheelhouse.

Skyline Medical markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement, and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. A video showcasing the system is available at (https://ibn.fm/GZGlG).

The STREAMWAY System is a major step forward compared to the way many hospitals currently deal with waste fluids, which can amount to dozens of liters from a patient during a single operation. Operating under today’s standards, once a waste fluid container is filled, it is wheeled down a hallway to be emptied. This can even mean stopping mid-operation to empty a container.

The wall-mount STREAMWAY System ties into a facility’s existing plumbing system. During a surgery or procedure, a single-use filter is snapped into place, a suction tube connected to the unit and proper vacuum level programmed into the display, and the unit takes it from there, calculating the collected amount of fluid while safely disposing of it through the drain system.

For interventional radiology procedures, such as paracentesis and thoracentesis, the unit can also be programmed to remove a designated amount of fluid. Once complete, the filter is disposed of and a bottled STREAMWAY solution is attached to the unit, cleaning it in less than five minutes. The system is centered on elimination of waste transport, disposal costs, equipment relocation and risk of exposure to potentially contaminated fluids.

The new generation of the system will include:

  • A 25% reduction in unit size
  • Modularized subassemblies and drop-down cover to streamline assembly and servicing
  • Upgraded software providing state-of-the-art on-screen graphics
  • New technology for on-screen training as required.
  • An automated dripless system for filter changes between procedures
  • Reduced electrical and mechanical internal connections increasing vacuum efficiency
  • New integrated PC board providing real-time fluid waste management
  • Eliminated relays and inputs/outputs

“Skyline Medical plans to follow shortly with a Generation 3 Plus machine, which includes an integrated on board vacuum pump so the facility vacuum supply will not be required or at the very least can be augmented if needed,” commented Predictive Oncology CEO Dr. Carl Schwartz.

Overall, the new design will be smaller, lighter, and easier to install with the goal of improving operator reliability, reducing manufacturing costs, increasing durability and simplifying servicing. From a regulatory standpoint, the changes do not affect the intended use of the system, meaning no separate 501(k) medical device submission is required with the Food and Drug Administration.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Remains on Schedule to bring in Bladder Cancer Imaging System to Market

  • Bladder cancer is the fourth most common cancer in men andexpected to cause more than 17,000 deaths in the United States this year
  • Imagin Medical is advancing its patented bladder cancer visualization technology toward commercialization and FDA approval, expecting the technology to revolutionize blue light cystoscopy procedures and improve patient outcomes in the process
  • Imagin is funding its efforts with $2.165 million raised towards its convertible note offering
  • Rollout of the company’s manufacturing process was delayed about nine months as a result of the COVID-19 pandemic.but Imagin and its production partner remain on its revised schedule
  • The company expects to expand its product line once the bladder cancer technology rolls out, adapting its IP for use with other contrast dyes so the technology can be used in additional endoscopic procedures

Imagin Medical (CSE: IME) (OTCQB: IMEXF) announced on March 16 that its product development partner, ISO 13485:2016-certified manufacturer, Lighthouse Imaging, is making progress towards commercial-stage manufacturing capability of the novel, state-of-the-art bladder i/Blue Imaging System (TM) for use in bladder cancer visualization procedures.

“Prior to Imagin’s selection of Lighthouse as its contract manufacturer for the i/Blue Imaging System (TM) in October 2020, the Company received multiple fully functional feasibility units from its original design partner, Optel, Inc.,” the news release states (https://ibn.fm/34rXB). “Lighthouse’s development program has since focused on further refining the design to support Imagin’s submissions to the U.S. Food and Drug Administration and to ensure final device performance, compliance with all applicable regulatory standards, and optimal manufacturability to meet both cost targets and anticipated user demand.”

The i/Blue Imaging System will improve the ability of surgeons to view bladder tumors during cystoscopy procedures. Bladder cancer is the sixth most prevalent cancer in the US and the fourth most common cancer in men and was expected to directly result in more than 17,000 deaths during the past year in the United States, with similar statistics anticipated for 2021 (https://ibn.fm/wcmFw).

The challenge for surgeons is to get a full view of any tumors on the bladder wall so they can be removed in their entirety. The existing technique of using blue light in cystoscopies to view tumors stained with a pink contrast dye makes it possible for them to view all the contours of the tumors and ensure they are completely removed, potentially reducing the rate of recurrence in a cancer renowned for its repeat incidence rate.

Blue light cystoscopy is still an emerging technique, despite its reported rate of success and cost-effectiveness in medical studies (https://ibn.fm/66wE3). Two primary obstacles to wider adoption identified by Imagin include a reluctance by hospitals and clinics to upgrade existing equipment, and the technological imposition of blue light procedures that require surgeons to repeatedly switch back and forth between standard white light camera images and blue light camera images as they visualize the patient’s internal landscape.

Imagin’s patented system responds to both concerns, first by developing a device that can easily be adapted to nearly all existing cystoscopes, eliminating the need to replace surgical tools they already own, and second, by establishing a camera system that delivers white and blue light images side-by-side on a single screen so they can be viewed simultaneously.

The advent of the COVID-19 pandemic set the transition from development to manufacturing back by about nine months, meaning the system will be available for commercial production in 2022. In the meantime, Lighthouse continues laying the groundwork for meeting the FDA’s rigorous standards for surgical devices.

The good news is that Lighthouse’s program has stayed on schedule and we expect it to remain on target going forward,” Imagin CEO and President Jim Hutchens stated.

The project is primarily being funded by a $3 million convertible note Imagin undertook late last year (https://ibn.fm/yKZHJ).

For more information, visit the company’s website at www.ImaginMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTCQB: ISGIF) Expands Hospitality Liability Coverage to Offer Worldwide Protection to U.S.-Based Customers

  • InsuraGuest Technologies is a leading insurtech (insurance + technology) company that offers its Hospitality Liability coverage to the hotels and vacation rental sectors
  • The latest expansion will offer accidental medical protection to hotels and vacation rental customers who also own properties abroad
  • The company is looking to enter the European and Canadian markets in 2021, two promising markets, given the size of the SMEs and projections on revenue generated from the traditional hospitality sector and vacation/holiday rental homes
  • InsuraGuest already has existing insurance partnerships with leading underwriting companies and distribution with major insurance agencies
InsuraGuest Technologies (TSX.V: ISGI) (OTCQB: ISGIF), a leading insurtech company that is leveraging its proprietary software platform to disrupt the insurance landscape, has expanded its Hospitality Liability coverages to include worldwide accidental medical protection for U.S.-based customers. Through the wholly owned U.S. subsidiary InsuraGuest Hospitality, the company will now provide coverage to U.S. hotel and vacation rental customers that have properties located outside the country (https://ibn.fm/XDue0). This decision is in line with the company’s plans to expand the reach of its insurtech platform and services worldwide, starting with the European and Canadian markets. “It has always been our goal to expand InsuraGuest worldwide so we can capture the 6.8 billion hotel nights stayed and 448.7 million vacation rental users in major worldwide markets,” InsuraGuest Technologies Chairman and CEO Douglas Anderson explained. “Our ability to offer the accidental medical portion of our Hospitality Liability coverage to our U.S. members’ properties worldwide is the first step for us to become the global provider we have envisioned.” A look at the European and Canadian markets shows the motivation behind this expansion drive. A publication by the European Commission shows that small and medium-sized enterprises (“SMEs”) contribute 50% of Europe’s GDP. As at March 2020, there were 25 million SMEs, which employed 2 out of 3 Europeans (https://ibn.fm/7D8mU). The European vacation/holiday rental homes are projected to generate about $23.99 billion in revenue in 2021, with the figure expected to reach $34.18 billion by 2025 (https://ibn.fm/ChzOP). The revenue from Canadian holiday rental homes is forecasted to reach $1.40 billion in 2021 and $1.90 billion by 2025 (https://ibn.fm/0w1P1). These figures exclude the income from the traditional hospitality industry, which is expected to generate $79 billion and $4.89 billion in 2021 in Europe and Canada, respectively. To back this expansion, InsuraGuest already has existing partnerships with underwriters and distribution with major insurance agencies to sell in these new markets. Therefore, they looks well-positioned to enter the new market successfully. InsuraGuest is transforming the way insurance is delivered, and the fact that it is eyeing new markets means that it is looking at the transformation from a global perspective. InsuraGuest Technologies is at the center of a global, technology-driven insurance shakeup. A McKinsey report on the digital disruption in insurance terms the present era as “The age of innovation. Insurers have a choice: be disrupted or be the disruptor with new products, services, and business models.” It further discussed new ways in which technology has disrupted and is disrupting the insurance sector, among them the fact that new underwriting approaches have emerged. One such disruption, which InsuraGuest’s products happen to be a part of, is on-demand insurance. The report continues, “In addition to facilitating the underwriting of small amounts of cover, real-time data can enable the provision of ‘episodic’ or on-demand cover for short periods” (https://ibn.fm/ChS42). This statement perfectly describes two of InsuraGuest. The company’s platform provides digital insurance to multiple sectors, making it well-suited for the current insurance market conditions. Further, the software platform supports multiple property management systems used in the hospitality industry – over 82 PMS systems available in the market – through back-end integration, enabling it to deliver the Hospitality Liability coverage. This coverage, a specialized insurance policy covering property, casualty, accidents, and health claims, is activated when a guest checks in and deactivates once they check out. This insurance policy is also unique because it passes the cost to the guest (https://ibn.fm/S1u6U) and is available for hotels and vacation rental properties. The InsuraGuest solution further helps hospitality operators lower their insurance premiums and risks deriving from third-party liability claims by absorbing the risks itself. The majority of hotel operators file their accident or small property claims through their general liability policies, resulting in higher premiums. The higher the risk, the higher the general liability insurance prices will be. InsuraGuest changes this dynamic by transferring the risk from the hospitality operator by having guests pay a nominal fee per night. InsuraGuest then pays out the coverage for these small claims, potentially keeping the hotel operator’s general liability premiums untouched, resulting in lower expenses for property owners. For more information, visit the company’s website at www.InsuraGuest.com. NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Sees 298% Increase in Revenue Quarter over Quarter

  • Company reports Q3 gross revenue of C$1,832,484, an increase from Q2 gross revenue of C$459,982
  • PlantX becoming digital face of plant-based community through e-commerce, flagship locations
  • Revenue growth attributed to expanded product offerings, innovative partnerships and strategic acquisitions
PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers with all things plant based, reported triple-digit growth from Q2 2020 to Q3 2020 (https://ibn.fm/pUSrX). The significant increase emphasizes the company’s impact and potential in the plant-based marketplace. Financial records released by PlantX on March 1, 2021, show the company generated gross revenue of revenue of C$1,832,484 for the three months ended December 31, 2020, an increase of 298% from Q2 gross revenue of C$459,982. Over the same period, PlantX achieved a gross margin of 20%, an increase from 5.7% in Q2. These impressive numbers seem to indicate the company, which launched barely one year ago, is achieving its mission: to become the digital face of the plant-based community by being the first known, publicly listed one-stop shop for all things plant-based. Through e-commerce and state-of-the-art flagship locations, PlantX is building a community of like-minded people by providing:
  • plant-based grocery items
  • meal delivery (currently in Canada only but plans to expand to the United States)
  • plant-based pet supplies
  • beauty and personal care items
  • home plant delivery
  • recipes
  • forums
  • partnerships with restaurants, nutritionists, chefs and brands
“The company’s increase in revenue and sales during a highly unprecedented year positions PlantX as one of the highest growing leaders in the plant-based industry,” said PlantX CEO Julia Frank. “The company attributes its revenue growth to its expanded product offerings, innovative partnerships and strategic acquisitions.” PlantX product offerings range from a variety of plant-based grocery items to chef-curated meals and home plant delivery. The company’s online shop offers more than 5,000 plant-based products with more added daily. PlantX strives to offer something for everyone, wherever they are at on their plant-based journey. Products can be browsed by one’s individual dietary needs and preferences. PlantX has also created several innovative partnerships and strategic acquisitions. For instance, through a partnership with Geoponics Inc. and House Plant Shop, the company provides home plant delivery across Canada and the United States. The company has also acquired Bloombox Club UK, which plans to expand to the rest of Europe and then into the American market. PlantX is also looking to further partner with restaurants to help them accommodate plant-based, vegan and vegetarian customers. Currently, the plant-based food industry is experiencing record growth as more consumers rethink their diets and gravitate towards plant-based health benefits. Overall, online grocery sales grew by 53% in 2020 (https://ibn.fm/FJDVl), and by 2027, the plant-based food market is expected to reach $74.2 billion (https://ibn.fm/QcYH1). Those two numbers bode well for PlantX as the company is working to be ideally positioned in this burgeoning space. In just over a year, the company has seen remarkable growth — including record revenue numbers — and looks to be well on its way to becoming one of the most trusted and convenient destinations for consumers choosing to live plant-based lives. For more information, visit the company’s websites at www.PlantX.comwww.PlantX.ca and www.Investor.PlantX.com. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

Ideanomics, Inc. (NASDAQ: IDEX) Targets Global Markets Providing Shareholders with High-Growth Opportunities

  • Ideanomics raised $400 million in the last few months for growth and investment opportunities
  • IDEX recently signed an agreement with Italian-based high-performance electric motorcycle company Energica, to acquire at least 20% of the company
  • Company CEO Alf Poor to address a presentation on EV technology at the KraneShares’ Future of Green ETFs Summit

Ideanomics (NASDAQ: IDEX) is a global company focused on EV and fintech businesses. Founded in 2004 and headquartered in New York, Ideanomics currently spans operations in United States, China, Ukraine, and Malaysia. After raising $400 million in the past few months, the company is looking for high-growth avenues and disruptive opportunities in its two divisions: Mobility and Capital.

As a part of its latest mobility investment, Ideamonics signed an agreement with Energica Motor Company S.p.A. (“Energica”), a listed high-performance Italian electric motorcycle company. As per the arrangement, IDEX will purchase 64% of the share capital increase, the equivalent of 6,128,703 Energica ordinary shares, in a subscribed-shares arrangement. With this collaboration, IDEX will acquire at least 20% of Energica, for $13.2 million, expanding its global footprint in the electric vehicle (“EV”) industry. This investment complements Treeletrik’s business in the ASEAN market and marks Ideanomics continued investment in European-based OEM (https://ibn.fm/1whQB).

IDEX CEO Alf Poor will be delivering a presentation on EV and battery trends and outlook at the KraneShares’ Future of Green ETFs Summit, this month. This conference will witness investors from the US, Europe, and Asia showcasing their opinion on ESG considerations in their portfolios. The conference will witness a global presence of companies inlcuding leading OEM NIO spearheading renewable energy projects and sustainable investment strategies, along with pollution reduction in China (https://ibn.fm/PTvTP).

For more information, visit the company’s website at www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) Visualizing Advertising, e-Commerce, Events in 3D

  • Pioneering augmented reality technology company Nextech AR Solutions is advancing the use of 3D / AR wizardry for practical applications that improve marketing and consumer experiences
  • Nextech’s verticals include AR-enhanced virtual conference platforms, 3D advertising solutions, an app for e-commerce that includes “Try It On” technology, and a similar Hollywood Studios app for creating 360-degree videos
  • The company’s revenues have grown from $6 million in 2019 to a forecast of $50 million to $60 million this year
  • Among the contracts that Nextech has provided support for is February’s Student Veterans of America’s (SVA) 2021 National Conference, which featured first lady Dr. Jill Biden as its keynote speaker and other national luminaries on the agenda
Barely a generation ago, “flip phone” cell phones became a novelty that allowed consumers to play with pocketable Star Trek nostalgia-level communications technology on a broad market scale. But it didn’t take long before the nostalgia surrendered to the utility of slide-open phones, then the quantum leap in connective technology that flat-faced smart phones offered (https://ibn.fm/FEpEn). Enterprising augmented reality pioneer Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF), based in Vancouver, Canada, is similarly working to mainstream AR functionality beyond simple gimmickry, enabling educators, events managers, advertisers and consumers to engage their audiences in a more immersive way using AR and 3D imaging, holographic displays and 360-degree portals. “When we look at 2021, I see lots of catalysts for our company,” Nextech AR CEO and founder Evan Gappelberg said during a recent Virtual Investor Conferences webcast and Q&A. “Beyond just revenue, we have launches of new major brands for our e-commerce division. … We’re also working very hard on launching new technology, especially in our AR division, which includes getting to market with the holy grail of AR, which is beaming a live volumetric human as a hologram in our AiRShow app.” “We’re also working hard on bringing the AR room to the market for consumers as a standalone product,” Gappelberg added. “Right now it’s in our platforms but we plan on launching it as a standalone this year, which will be a Zoom lookalike only better since we have AI and AR.” As a virtual experience company, Nextech AR is dedicated to empowering people to achieve a better future for themselves through SaaS platforms that create “infinite experiences that inspire the world,” as the company’s website states. In terms of helping companies enhance their revenue potential, Nextech AR has or is developing tech verticals that include AR-enhanced virtual conference platforms, 3D advertising solutions, an Aritize360 (TM) app for e-commerce that includes “Try It On” technology via the virtual experience, and a Hollywood Studios version of the same app for creating 360-degree videos. The company’s products have been garnering attention. Gappelberg noted that in 2019, Nextech AR Solutions generated $6 million in revenue. In 2020, the company pre-announced its bookings at $20 million, and the company anticipates its 2021 revenues will land between $50 million and $60 million. Nextech’s Virtual Experience Platform (“VXP”) was chosen to host the Student Veterans of America’s (SVA) 2021 National Conference in February, which included a keynote address by first lady Dr. Jill Biden and other speakers such as author Gary Vaynerchuk, actress, neuroscientist and author Mayim Bialik, and Secretary of Veterans Affairs Denis McDonough. “I’m very proud of our Nextech delivery team who flawlessly pulled off this high-profile event. It is a great honor for our young company to be selected to work with SVA to build an engaging and secure venue for veterans and high-profile thought-leaders,” Gappelberg stated following the event (https://ibn.fm/fUEZi). The company also announced the launch of its ad network this month (https://ibn.fm/9OsyX), granting it a pipeline for connecting advertisers to websites that want to host advertisements utilizing its owned-and-operated virtual event platforms audience and ability to create attention-getting AR-capable communications. For more information, visit the company’s website at www.NextechAR.com. NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

Splash Beverage Group Inc. (SBEV) Is ‘One to Watch’

  • Splash Beverage Group Inc. is a portfolio company of successful beverage brands
  • The company’s growth strategy is based on incubating and acquiring brands to drive value through superior production, supply chain efficiency and global distribution capabilities
  • Splash focuses exclusively on brands with pre-existing brand awareness or those that are truly innovative
  • The current brands in the Splash portfolio each have a unique offering that fits into the core values of the company
  • TapouT provides high-performance sports drinks and is an official training partner of the WWE
  • The Splash management team is made up of executives who have been in the beverage industry or worked with sports nutrition for numerous years
  • The global beverage industry was valued at $1.5 trillion in 2018 and is expected to reach $1.9 trillion in 2024, providing ample growth opportunities
Splash Beverage Group (OTCQB: SBEV) is a portfolio company of successful beverage brands with the objective of driving value through superior production, supply chain efficiency and global distribution capabilities. Specializing in manufacturing, distributing, sales & marketing of various beverages across multiple channels, the company operates in both the alcoholic and non-alcoholic beverage segments, allowing it to leverage efficiencies and dilute risk. The company’s business strategy is to quickly develop and/or accelerate pre-existing brands to exit for cash events. Led by a highly successful management team, the company only works with brands it perceives to have highly visible preexisting brand awareness or pure category innovation, thus breaking through the clutter. Splash seeks out brands offering products that:
  • Deliver natural quality, health benefits, freshness and refreshment within their beverages;
  • Are on trend with consumers;
  • Have a high level of brand awareness;
  • Maintain highest performance standards and focus on execution;
  • Help distributors and retail partners achieve and exceed all goals; and
  • Offer unapologetic support for members of the U.S. armed forces, first responders and health care professionals.
Splash was founded in 2013 and is located in Fort Lauderdale, Florida. Splash Portfolio The current Splash portfolio includes four unique beverage brands. Each of these brands offers one or more of the qualities that the company specifically seeks in an acquisition.
  • TapouT Performanceis a natural isotonic hydration & recovery sport drink featuring a 3-in-1 advanced formula. TapouT Performance restores what the body loses through physical exertion, delivering hydration and cellular recovery. Perfectly balanced with key vitamins & minerals and all five necessary electrolytes, TapouT increases nutrient absorption, allowing the body to recover quickly and more efficiently. TapouT is the official training partner of the WWE (NYSE: WWE).
  • Salt Naturally Flavored Tequilais a 100% blanco agave 80 proof tequila that offers a clean and delicate taste. Salt is grown, distilled and bottled in the Jalisco region of Mexico. Every bottle of Salt Tequila is the result of hard work, determination and numerous blends. The brand offers a line of tequila flavors for enhanced refreshment, including berry, citrus and salted chocolate.
  • Copa Di Vinois the leading producer of premium “wine by the glass” in the U.S. Produced in the Columbia Valley, Copa di Vino is readily available on the go without the requirement of a bottle, corkscrew or glass. Open, drink and enjoy.
  • Pulpoloco Sangriais a premium crafted sangria imported from Spain. Its flavor is light-bodied, fruity and refreshing, offering the best blend of Spanish ingredients. The product is filled and packed in a unique eco-friendly biodegradable catocan, allowing Pulpoloco to extend the shelf life of the sangria without the use of preservatives.
Market Outlook The global beverage industry was valued at $1.5 trillion in 2018 and is projected to grow at a CAGR of 3.1%, reaching a market size of $1.9 trillion by 2024 (https://ibn.fm/QvJJS). The push for non-alcoholic beverages that are healthier and contain zero sugar is expected to be a driving force in the forecast period and beyond. With a seasoned management team and sufficient capital to fuel sustained growth, Splash is uniquely positioned to capitalize on this market growth. The company is currently preparing a secondary offering and has engaged Kingswood Capital Markets as lead underwriter in order to uplist to the Nasdaq or NYSE in the near future. Management Team Robert Nistico is the Chairman and CEO of Splash Beverage Group. He has 28 years of experience in the beverage industry and was the fifth employee and SVP/General Manager of Red Bull North America. In this role, he led the start-up from zero sales to $1.65 billion in annual sales. Mr. Nistico was a founder and President of Marley Beverages and was responsible for framing the company’s long-term vision. Mr. Nistico held executive positions at DIAGEO, Republic National Distributing Company and the Gallo Wine Company resulting in decades of successful experience in the ‘Three Tier Beverage System’. In the spirit of his true entrepreneurial nature, he is a motivated, results-driven, creative and passionate leader. William Meissner is the company’s President and CMO. He boasts over 20 years of success in growing consumer brand companies with large and medium-sized entrepreneurial organizations, both locally and internationally. His résumé includes multiple CEO roles, leading efforts to revamp both healthy and distressed companies. Before joining Splash, Mr. Meissner was the President and CEO of Sweet Leaf and Tradewinds Tea. He has held multiple positions with leading companies in the beverage sector, including Sparkling Ice, Jones Soda, SoBe Beverages, Fuze & NOS (Coca-Cola) and many others. Sanjeev Javia is the Vice President of Product Development for Splash. He is the founder and President of Javia Wellness Group, a firm focusing on the innovation, research, formulation and design of healthy exercise and wellness initiatives. Mr. Javia is a sports nutrition expert, allowing him the advantage of developing innovative functional beverages that include health benefits for consumers. Since 2000, he has advised and written nutritional plans for hundreds of the world’s most famous athletes, including Tom Brady, Kurt Warner, Curt Schilling and more. Dean Huge is the company’s Chief Financial Officer. He brings 35 years of public and private sector accounting and finance experience to the Splash Beverage team. Mr. Huge has led four public offerings as CFO and guided the growth efforts of numerous companies, including Catalyst Energy Corp., which was named Inc. Magazine’s ‘Fastest Growing Company’ within 36 months of his joining. His expertise spans financial services, manufacturing, distribution and SAAS-type programs. Aida Aragon is the company’s Senior Vice President of National Accounts. She is a sales, marketing and brand management executive with years of experience working in the sports supplement and beverage industry. In her previous positions, Ms. Aragon was vital in leading successful store rollouts for brands including Muscle Milk. Her passion for brand development comes as second nature, but her true passion has always been focused on increasing sales for brands in the sports nutrition industry. For more information, visit the company’s website at www.SplashBeverageGroup.com. NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

From Our Blog

From Capital to Catalysts: Canamera Energy Metals Corp.’s (CSE: EMET) (OTCQB: EMETF) $10M Raise Sets the Stage for Rare Earth Exploration Momentum

May 4, 2026

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF), a critical metals and rare earth exploration company, has recently made a company update announcement and shared more information about exploration and development activities across the company’s rare earth element (“REE”) and […]

Rotate your device 90° to view site.